Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: GlaxoSmithKline Biologicals S.A
Woman Max 99 years
GlaxoSmithKline Biologicals S.A
Update Il y a 4 ans
Testing of the liquid and lyophilized formulation of a vaccine on non-pregnant women that are 18 to 40 years old to asess its safety and the protection it gives from blood poisoning caused by a bacterium
Immunogenicity Objectives To demonstrate the equivalence of the liquid GBS trivalent vaccine formulation to the lyophilized GBS trivalent vaccine formulation for serotypes Ia, Ib, and III, when admin...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals S.A
Update Il y a 4 ans
Trial to Assess Long-Term Persistence of Antibodies after GSK Meningococcal ABCWY Vaccination and Response to a Booster in Adolescents
Effectiveness: To evaluate the effectiveness of 3 doses of MenABCWY (administered according to a 0, 2, 6-month schedule) against a randomly selected panel of US endemic N. meningitidis serogroup B in...
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
GlaxoSmithKline Biologicals S.A
Update Il y a 4 ans
Revaccination of healthy non-pregnantwomen with a second dose of a vaccine to asess its safety and the protection it gives from blood poisoning caused by a bacterium
Immunogenicity Objective To evaluate the immunogenicity of a second dose of GBS Trivalent Vaccine (5 μg without adjuvant) administered approximately 4-6 years after the initial GBS vaccination, measu...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
GlaxoSmithKline Biologicals S.A
Update Il y a 4 ans
A clinical study to evaluate immune responses to rabies vaccine in adults who received different primary rabies vaccination regimens
Primary Objectives: Immunogenicity Objectives: 1. To compare the long-term (up to approx.10 years) persistence of antibody responses (i.e. time until antibody concentrations drop below 0.5 IU/mL) in...
Country
None
organs
None
Specialty
None
unknown
More information